HomeNewsOpinionTwo Years Of COVID-19 | It’s been a bumpy ride, but time to move on

Two Years Of COVID-19 | It’s been a bumpy ride, but time to move on

The changes due to COVID-19 are plenty, showing our resilience as a country, and our fighting spirit 

March 14, 2022 / 16:03 IST
Story continues below Advertisement
Nearly two years after an unprecedented lockdown triggered by Covid-19’s first wave, the crowds are back in Delhi’s popular markets. (Photo: Shubhangee Vyas via Unsplash)
Nearly two years after an unprecedented lockdown triggered by Covid-19’s first wave, the crowds are back in Delhi’s popular markets. (Photo: Shubhangee Vyas via Unsplash)

It’s been two years since a virus changed our lives, forever — mostly for the worse. COVID-19 has affected every aspect of our life — right from the way we work, to how we commute to our daily social interactions.

The first COVID-19 case in India was reported on January 30, 2020, in a medical student who had just returned from Wuhan, China. There was a brief lull after that, and then the cases started going up again in early March, mostly fuelled by infections detected in travellers from other countries. The epicentres were Maharashtra and Kerala, a trend which stayed on for the next two years.

Story continues below Advertisement

On March 11, 2020, the World Health Organization declared COVID-19 a pandemic.

India entered a harsh lockdown on March 25, when the country had 500 cases and 12 deaths cumulatively. The lockdown was based on an erroneous assumption that we could stamp out the infection if there was a lockdown for 21 days. There was wide support for the lockdown among the upwardly mobile upper-middle-class, but it was an extremely challenging situation for businesses and migrant labour. There was a large scale migration from cities to rural areas, with many families walking for days together.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show